Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa
Crossref DOI link: https://doi.org/10.1007/s40262-016-0502-4
Published Online: 2017-01-09
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nader, Ahmed
Beck, Denise
Noertersheuser, Peter
Williams, David
Mostafa, Nael
Funding for this research was provided by:
AbbVie
License valid from 2017-01-09